Partial resistance to the antimalaria drug artemisinin has increased across Uganda in recent years, according to surveillance results from multiple sites across the country between 2016 and 2022. In the majority of sites surveyed, more than 20% of Plasmodium falciparum parasites exhibited signs of resistance, defined as slow clearance of the organism from a person’s body after treatment.
Source: JAMA Online First